EUCTR2015-004846-25-BE进行中（未招募）1 期
Immunization against oxLDL in patients with lysosomal lipid diseases and associated metabolic disorders
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients of following diseases (characterized by lysosomal lipid storage or associated metabolic pathology)
- •° Familial hypercholesterolemia,
- •° Partial lipodystrophy (PPARg mutations and laminin A/C mutations)
- •- Intention to be treated and participate to the treatment
- •- Written informed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 5
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 7
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Medical conditions that may interfere with the study procedures: cancer Hodgkin lymphoma (all related to immune cells); autoimmune diseases; immune deficiency; splenectomy syndrome
- •- Alcohol abuse (quantitative limit >20g/day for men and >10g for women)
- •- Illiteracy
- •- Patients younger than 10 years.
- •- Any condition which in the opinion of the (co-) investigator might interfere with the evaluation of the study objectives.
研究者
相似试验
Unknown
早期 1 期
Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid DiseasesLipid Metabolism, Inborn ErrorsNCT02707211Universitaire Ziekenhuizen KU Leuven20
已完成
不适用
Effects of Low Density Lipoprotein Apheresis on Oxidative Stress and Endothelial/Vascular Smooth Muscle Cell Function in Patients with Peripheral Arterial Disease and End-stage Renal Diseaseperipheral artery disease, end-stage renal disease on hemodialysisJPRN-UMIN000000652Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine50
已完成
不适用
Dendritic cell vaccination in patients with Lynch Syndrome or colorectal cancer with MSIhereditary non-polyposis colorectal cancerLynch syndrome100836241001799010027656NL-OMON39056niversitair Medisch Centrum Sint Radboud25
进行中（未招募）
1 期
Dendritic cell vaccination in patients with Lynch Syndrome or colorectal cancer with MSI - DC vaccination in lynch syndrome patientsIn this study our primary objective is to induce or enhance an immune response to tumor antigens in Lynch syndrome mutation carriers (with and without colorectal adenomas or carcinomas) and patients with sporadic colorectal cancer (CRC) showing microsatellite instability (MSI-high), the hallmark of MMR dysfunction, and test the hypothesis that DC vaccination might be effective as prophylactic treatment in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch syndrome mutation carriers.EUCTR2008-005584-33-NLRadboud University Nijmegen Medical Centre25
已完成
不适用
Effects of hydroxytyrosol on protection of LDL particles from oxidative damage: a randomized, double-blind, placebo-controlled cross-over studyo disease, healthy volunteersDRKS00010859Wacker Chemie AG30